Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 210

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Natalizumab effects on immune cell responses in multiple sclerosis

Niino, Masaaki, Bodner, Caroline, Simard, Marie‐Lune, Alatab, Sudabeh, Gano, Dawn, Kim, Ho Jin, Trigueiro, Manuela, Racicot, Denise, Guérette, Christine, Antel, Jack P., Fournier, Alyson, Grand'Maison, Francois, Bar‐Or, Amit · 2006 · Annals of Neurology

Abstract

Objective: Our objective was to study in vivo biological effects of natalizumab on immune cell phenotype and function in multiple sclerosis (MS) patients. Methods: Blood was obtained before and after serial monthly natalizumab infusions to track functional expression of VLA‐4 and migratory capacity of immune cells. The impact of infusion on activation thresholds of immune cells was evaluated. Results: Preinfusion VLA‐4 expression differed across immune cell subsets. Natalizumab significantly, albeit partially, diminished VLA‐4 expression on circulating immune cells. Cell subsets were differentially affected. Treatment significantly decreased migratory capacity of immune cells, correlating well with changes in VLA‐4 expression. Effects of a single dose were not saturating and did not persist through the monthly dose interval. Infusion effect varied across patients but was remarkably stable in individual patients, over multiple infusions. Treatment significantly modulated proliferative responses of immune cells. Interpretation: To our knowledge, we provide first proof of concept that natalizumab diminishes migratory capacity of immune cells. Our prospective study further shows that effects of therapy likely (1) differ for distinct immune cell subsets, (2) are not sustained over current dose interval, (3) have unique profiles in individual patients, and (4) include modulation of activation threshold of immune cells. Monitoring these parameters could be relevant to ongoing safety and efficacy considerations. Ann Neurol 2006;59:748–754

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.20859

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

Metadata

Authors
Niino, M., Bodner, C., Simard, M., Alatab, S., Gano, D., Kim, H. J., Trigueiro, M., Racicot, D., Guérette, C., Antel, J. P., Fournier, A., Grand'Maison, F., & Bar‐Or, A.
Venue
Annals of Neurology
Publisher
Wiley
Published
2006-04-21
Volume
59
Issue
5
Pages
748-754
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2057903396
Cited by
210
References
2
FWCI
12.91
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.